Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

Robert F. Kushner*, Salvatore Calanna, Melanie Davies, Dror Dicker, W. Timothy Garvey, Bryan Goldman, Ildiko Lingvay, Mette Thomsen, Thomas A. Wadden, Sean Wharton, John P.H. Wilding, Domenica Rubino

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5'. Together they form a unique fingerprint.

Medicine & Life Sciences